January
Market Access and the Celtic Nations
Stay ahead with essential insight on access dynamics across the Celtic Nations
Join market access experts, Andrew Mumford and Allister Upton, as they explores changes across the Celtic Nations and how Life Sciences teams can adapt to the priorities, pressures and progress in 2026.
February
Building Health Economic Models for Beginners
Understand how to demonstrate value, cost-effectiveness and HTA readiness from day one
New medicines need more than evidence of efficacy. Join Keith Tolley for a beginner’s guide to building health economic models that support real-world reimbursement and HTA success.
Market Access NHS England: In conversation with Neil Grubert
What’s changing in NHS England’s market access landscape and what Life Sciences teams need to know now
NHS England is under pressure to reform, rebalance and deliver more value. Join market access expert Neil Grubert for a strategic look at how those shifts are playing out across access policy, payer priorities and evidence expectations in 2026.
Nordic Market Access Made Simple
Clear insight into payer pathways and decision-making across Denmark, Finland, Norway and Sweden
Join Nordic market access expert Katja Lundell for a practical guide to navigating payer pathways across the region. Gain clarity on how decisions are made, who holds influence and what strategies can speed patient access to innovative medicines.